Cardiology and Therapy·8 OctNeurologic Stability During Tafamidis Treatment in Transthyretin Amyloidosis with a Mixed Phenotype: A Multicenter Real-World StudyCohort study of 67 peopleInterventionsPaper
Journal of the American College of Cardiology·30 AugEffect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-BTrial in peopleInterventionsPaper
Journal of Cardiac Failure·21 AugInpatient Initiation of Target-Dose ACE Inhibitors and Lower Risk of Death or Kidney Failure in Veterans With HFrEF: Results From the National DCVA-HF RegistryStudy in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovVutrisiran Improved Outcomes Versus Placebo in Patients with Transthyretin Amyloidosis with Cardiomyopathy and Severe Chronic Kidney Disease: Post Hoc Analysis of HELIOS-BTrial in peopleInterventionsPaper